Optimizing Patient Safety and Outcomes by Individualizing Therapy

Optimizing Patient Safety and Outcomes by Individualizing Therapy

Since the approval of interferon beta-1b, multiple additional therapies ha…

Expiration Date: 11/12/2016

Max Credits: 0

View Activity

Making Informed Decisions When Screening and Monitoring

Making Informed Decisions When Screening and Monitoring

Since the approval of interferon beta-1b, multiple additional therapies ha…

Expiration Date: 11/12/2016

Max Credits: 0

View Activity

No evident disease activity in relapsing MS patients treated with interferon β-1a SC vs. interferon β-1a IM: subgroup analyses of the EVIDENCE study

No evident disease activity in relapsing MS patients treated with interferon β-1a SC vs. interferon β-1a IM: subgroup analyses of the EVIDENCE study

Dr. Coyle discusses the most current research on the effect of interferon …

Expiration Date: 11/12/2016

Max Credits: 0

View Activity

Long-term effects of fampridine on walking ability in patients with multiple sclerosis: a phase II, open-label, uncontrolled, monocenter study

Long-term effects of fampridine on walking ability in patients with multiple sclerosis: a phase II, open-label, uncontrolled, monocenter study

Dr. Filli discusses the most current research on the effect of fampridine …

Expiration Date: 11/12/2016

Max Credits: 0

View Activity

MicroRNA miR-21 is induced by interferon-beta and inhibits IL-12 expression: a novel immunomodulatory mechanism in multiple sclerosis

MicroRNA miR-21 is induced by interferon-beta and inhibits IL-12 expression: a novel immunomodulatory mechanism in multiple sclerosis

Dr. Balashov discusses the effect of interferon beta on interleukin-12 in …

Expiration Date: 11/12/2016

Max Credits: 0

View Activity

MS Forum

MS Forum

Multiple sclerosis (MS) is a chronic, immune-mediated inflammatory disease…

Expiration Date: 12/18/2015

Max Credits: 0

View Activity

Long-term treatment of intrathecal baclofen in multiple sclerosis: frequency and severity of withdrawal syndrome

Long-term treatment of intrathecal baclofen in multiple sclerosis: frequency and severity of withdrawal syndrome

Dr. Stetkarova discusses the use of intrathecal baclofen to treat MS patie…

Expiration Date: 11/12/2016

Max Credits: 0

View Activity

A novel MIF inhibitor as therapy for multiple sclerosis and stroke

A novel MIF inhibitor as therapy for multiple sclerosis and stroke

Dr. Vandenbark discusses the research on a strategy to treat all patients …

Expiration Date: 12/17/2015

Max Credits: 0

View Activity

Improving adherence in pediatric MS: feasibility of a randomized-control trial with a remote motivational interviewing intervention

Improving adherence in pediatric MS: feasibility of a randomized-control trial with a remote motivational interviewing intervention

Dr. Yeh discusses the research behind improving adherence in adolescent pa…

Expiration Date: 11/12/2016

Max Credits: 0

View Activity

Shifting the Paradigm in Multiple Sclerosis Treatment by Targeting New Pathways

Shifting the Paradigm in Multiple Sclerosis Treatment by Targeting New Pathways

Multiple sclerosis (MS) is an immune-mediated inflammatory disease that at…

Expiration Date: 11/16/2015

Max Credits: 0

View Activity